Niacin Won't Help, May Harm Heart Patients: Study

Taking the B vitamin offered no benefit in lowering cardiac deaths or heart attacks, researchers say

March 9, 2013 RSS Feed Print

The U.S. Food and Drug Administration had been waiting on the new trial results to decide whether to approve niacin/laropiprant for use against heart disease. But in December 2012, responding to preliminary findings, drug maker Merck said it no longer planned to press for approval from the FDA and in January suspended niacin/laropiprant from markets worldwide.

More information

The U.S. National Institutes of Health outlines steps you can take to reduce heart risks.